Abstract is: Michael Roden (born February 11, 1961) is Professor and Chairman of Internal Medicine, Endocrinology and Metabolic Disorders at Heinrich Heine University Düsseldorf, Director of the Division of Endocrinology and Diabetology at the University Hospital of Düsseldorf and Spokesman for the Executive Board and Scientific Director of the German Diabetes Center, the Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf (Legal body: Deutsche Diabetes-Forschungsgesellschaft eV).
human | Q5 |
P8168 | FactGrid item ID | Q885699 |
P227 | GND ID | 130812773 |
P2671 | Google Knowledge Graph ID | /g/12nx42crh |
P213 | ISNI | 0000000116559683 |
P244 | Library of Congress authority ID | n2007181800 |
P8189 | National Library of Israel J9U ID | 987007314988205171 |
P691 | NL CR AUT ID | uk2007408798 |
P1207 | NUKAT ID | n2008109799 |
P496 | ORCID iD | 0000-0001-8200-6382 |
P3368 | Prabook ID | 171159 |
P214 | VIAF ID | 61868926 |
P7859 | WorldCat Identities ID (superseded) | lccn-n2007181800 |
P166 | award received | Paul Langerhans Medal | Q1443256 |
Minkowski Prize | Q6867862 | ||
P27 | country of citizenship | Austria | Q40 |
P69 | educated at | University of Vienna | Q165980 |
P108 | employer | University of Düsseldorf | Q317032 |
P734 | family name | Roden | Q36898199 |
Roden | Q36898199 | ||
Roden | Q36898199 | ||
P735 | given name | Michael | Q4927524 |
Michael | Q4927524 | ||
P1412 | languages spoken, written or signed | German | Q188 |
P463 | member of | German Academy of Sciences Leopoldina | Q543804 |
P106 | occupation | researcher | Q1650915 |
diabetologist | Q20756907 | ||
P21 | sex or gender | male | Q6581097 |
Q91721267 | 1H-MRS of femoral red and yellow bone marrow fat composition and water content in healthy young men and women at 3 T |
Q90644458 | 4-Methylumbelliferone improves the thermogenic capacity of brown adipose tissue |
Q57314994 | 5 Jahre erfolgreiche translationale Forschung – Deutsches Zentrum für Diabetesforschung |
Q38877389 | A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk |
Q64060150 | A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver |
Q104682641 | A Panel of Six Biomarkers Significantly Improves the Prediction of Type 2 Diabetes in the MONICA/KORA Study Population |
Q60056850 | A Systemic Inflammatory Signature Reflecting Cross Talk Between Innate and Adaptive Immunity Is Associated With Incident Polyneuropathy: KORA F4/FF4 Study |
Q56987585 | A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects |
Q28740367 | A genome-wide association search for type 2 diabetes genes in African Americans |
Q28544644 | A meta-analysis of gene expression signatures of blood pressure and hypertension |
Q114231551 | A novel diabetes typology: towards precision diabetology from pathogenesis to treatment |
Q37635746 | A role for mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) in the regulation of hepatic gluconeogenesis |
Q35688286 | A single nucleotide polymorphism associates with the response of muscle ATP synthesis to long-term exercise training in relatives of type 2 diabetic humans |
Q58563446 | A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes |
Q44899671 | Abnormal hepatic energy homeostasis in type 2 diabetes |
Q33803480 | Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study |
Q37610702 | Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance |
Q36782799 | Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study |
Q40960591 | Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis |
Q58418621 | Adiponectin and Bariatric Surgery: Associations With Diabetes and Cardiovascular Disease in the Swedish Obese Subjects Study |
Q41317817 | Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study |
Q36426822 | Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study. |
Q47124586 | Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study. |
Q40998127 | Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes |
Q36377713 | Adipotoxicity and the insulin resistance syndrome. |
Q56984696 | Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract |
Q45161282 | Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes |
Q38825726 | Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus |
Q47613651 | Amino acid and fatty acid levels affect hepatic phosphorus metabolite content in metabolically healthy humans |
Q89412030 | Amino acids - lifesaver or killer in patients with diabetes? |
Q60926597 | An 8-week diet high in cereal fiber and coffee but free of red meat does not improve beta-cell function in patients with type 2 diabetes mellitus: a randomized controlled trial |
Q38752732 | An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans |
Q30581339 | Analyzing illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the metaxpress consortium |
Q61451341 | Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 |
Q62774772 | Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 |
Q40187016 | Anxiety Associated Increased CpG Methylation In The Promoter of Asb1: A Translational Approach Evidenced By Epidemiological And Clinical Studies And A Murine Model |
Q40944811 | Assessing multiple features of mitochondrial function |
Q39412026 | Association Between Long-term Exposure to Air Pollution and Biomarkers Related to Insulin Resistance, Subclinical Inflammation, and Adipokines |
Q35644178 | Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study |
Q92958960 | Association between Biomarkers of Low-grade Inflammation and Sex Hormones in Women with Polycystic Ovary Syndrome |
Q35971447 | Association between DNA Methylation in Whole Blood and Measures of Glucose Metabolism: KORA F4 Study |
Q54224164 | Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes-potential differences by diabetes type and depression scores. |
Q28661191 | Association between traffic-related air pollution, subclinical inflammation and impaired glucose metabolism: results from the SALIA study |
Q104566058 | Association of Long-Term Air Pollution with Prevalence and Incidence of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study |
Q53832623 | Association of Methylation Signals With Incident Coronary Heart Disease in an Epigenome-Wide Assessment of Circulating Tumor Necrosis Factor α. |
Q35213584 | Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants |
Q100756509 | Association of cardiac autonomic dysfunction with higher levels of plasma lipid metabolites in recent-onset type 2 diabetes |
Q90982691 | Association of changes in inflammation with variation in glycaemia, insulin resistance and secretion based on the KORA study |
Q50135431 | Association of lower cardiovagal tone and baroreflex sensitivity with higher liver fat content early in type 2 diabetes. |
Q41602580 | Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study |
Q37278173 | Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study |
Q54190785 | Association of transketolase polymorphisms with measures of polyneuropathy in patients with recently diagnosed diabetes. |
Q90268131 | Associations Between Migration Background and Media and Information Behavior in Primary School Children |
Q96586458 | Associations between HbA1c and mortality over long-term follow-up: Results from the KORA S4 and the Heinz Nixdorf Recall Study |
Q90835358 | Associations between cognitive performance and Mediterranean dietary pattern in patients with type 1 or type 2 diabetes mellitus |
Q37291712 | Associations between explorative dietary patterns and serum lipid levels and their interactions with ApoA5 and ApoE haplotype in patients with recently diagnosed type 2 diabetes |
Q40399988 | Associations between inflammation-related biomarkers and depressive symptoms in individuals with recently diagnosed type 1 and type 2 diabetes |
Q33701197 | Associations between thyroid hormones and serum metabolite profiles in an euthyroid population |
Q100691678 | Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study |
Q91044631 | Athletes feature greater rates of muscle glucose transport and glycogen synthesis during lipid infusion |
Q92473533 | Augmented Corneal Nerve Fiber Branching in Painful Compared With Painless Diabetic Neuropathy |
Q91468905 | Authors' response to the commentary by Bonaventura and Montecucco on: 'Characterization of circulating leukocytes and correlation of leukocyte subsets with metabolic parameters 1 and 5 years after diabetes diagnosis' |
Q57813580 | Autoimmunity risk- and protection-associated IL7RA genetic variants differentially affect soluble and membrane IL-7Rα expression |
Q94566177 | Bax inhibitor-1 deficiency leads to obesity by increasing Ca2+-dependent insulin secretion |
Q90275168 | Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease-a comparison in the MONICA/KORA study |
Q98907587 | Biomarkers of inflammation and glomerular filtration rate in individuals with recent-onset type 1 and type 2 diabetes |
Q40620897 | Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2 diabetes: the KORA F4 study |
Q40636102 | Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study. |
Q33685725 | Blood cis-eQTL analysis fails to identify novel association signals among sub-threshold candidates from genome-wide association studies in restless legs syndrome |
Q33523883 | Blood glucose testing and primary prevention of diabetes mellitus type 2--evaluation of the effect of evidence based patient information |
Q53118076 | Body and liver fat content and adipokines in schizophrenia: a magnetic resonance imaging and spectroscopy study. |
Q34507228 | Body and liver fat mass rather than muscle mitochondrial function determine glucose metabolism in women with a history of gestational diabetes mellitus |
Q33255497 | C-peptide does not affect ocular blood flow in patients with type 1 diabetes |
Q48093022 | CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility |
Q33852008 | Carbohydrates from Sources with a Higher Glycemic Index during Adolescence: Is Evening Rather than Morning Intake Relevant for Risk Markers of Type 2 Diabetes in Young Adulthood? |
Q89968634 | Cardiometabolic risk factor clustering in patients with deficient branched-chain amino acid catabolism: A case-control study |
Q50074042 | Cardiorespiratory Fitness and Cardiac Autonomic Function in Diabetes. |
Q35587187 | Cell Specific eQTL Analysis without Sorting Cells |
Q57987721 | Cell specific eQTL analysis without sorting cells |
Q88189753 | Central Regulation of Glucose Metabolism in Humans: Fact or Fiction? |
Q52584112 | Characterization of circulating leukocytes and correlation of leukocyte subsets with metabolic parameters 1 and 5 years after diabetes diagnosis. |
Q41717341 | Characterization of the peak at 2.06 ppm in (31) P magnetic resonance spectroscopy of human liver: phosphoenolpyruvate or phosphatidylcholine? |
Q34699554 | Chronic TNF-α neutralization does not improve insulin resistance or endothelial function in "healthy" men with metabolic syndrome |
Q39253446 | Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease: Meta-Analysis of Six Population-Based Cohorts |
Q47570450 | Circulating triacylglycerols but not pancreatic fat associate with insulin secretion in healthy humans |
Q58792785 | Cognitive Function Is Impaired in Patients with Recently Diagnosed Type 2 Diabetes, but Not Type 1 Diabetes |
Q36774677 | Cohort profile: the German Diabetes Study (GDS). |
Q34355379 | Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways |
Q35147540 | Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance |
Q84766604 | Comparison of measuring energy metabolism by different (31) P-magnetic resonance spectroscopy techniques in resting, ischemic, and exercising muscle |
Q93131277 | Comparison of the diagnostic accuracy of the current guidelines for detecting insulinoma |
Q47976945 | Constant hepatic ATP concentrations during prolonged fasting and absence of effects of Cerbomed Nemos® on parasympathetic tone and hepatic energy metabolism. |
Q48520693 | Correction: Reinauer et al., The Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ Genotype. Genes 2017, 8, 146. |
Q56879642 | Corrigendum: Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis |
Q104793971 | DNA methylation and lipid metabolism: an EWAS of 226 metabolic measures |
Q37234351 | DNA methylation of lipid-related genes affects blood lipid levels |
Q92350539 | DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity |
Q53040218 | Deep subcutaneous adipose tissue lipid unsaturation associates with intramyocellular lipid content. |
Q91710271 | Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy |
Q28729748 | Determinants of aortic stiffness: 16-year follow-up of the Whitehall II study |
Q92151133 | Diabetes and Fatty Liver |
Q90766211 | Diabetes clusters and risk of diabetes-associated diseases - Authors' reply |
Q40408656 | Diabetes prevalence in NZO females depends on estrogen action on liver fat content. |
Q40652070 | Diabetic LDL triggers apoptosis in vascular endothelial cells |
Q61827265 | Diabetische Nephropathie – Update 2012 |
Q99401504 | Dietary Rapeseed Oil Supplementation Reduces Hepatic Steatosis in Obese Men - A Randomized Controlled Trial |
Q102053569 | Differences in Physiological Responses to Cardiopulmonary Exercise Testing in Adults With and Without Type 1 Diabetes: A Pooled Analysis |
Q42127089 | Differences in troglitazone action on glucose metabolism in freshly isolated vs long-term incubated rat skeletal muscle |
Q35493790 | Differential Patterns and Determinants of Cardiac Autonomic Nerve Dysfunction during Endotoxemia and Oral Fat Load in Humans |
Q51296722 | Differential Patterns of Impaired Cardiorespiratory Fitness and Cardiac Autonomic Dysfunction in Recently Diagnosed Type 1 and Type 2 Diabetes. |
Q54535078 | Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: results from the KORA F4 study. |
Q48547277 | Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed type 1 and type 2 diabetes. |
Q31107112 | Direct noninvasive quantification of lactate and high energy phosphates simultaneously in exercising human skeletal muscle by localized magnetic resonance spectroscopy |
Q28546045 | Discovery and Fine-Mapping of Glycaemic and Obesity-Related Trait Loci Using High-Density Imputation |
Q91853394 | Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice |
Q33765953 | Do mitochondria care about insulin resistance? |
Q90100592 | Dynamic changes of muscle insulin sensitivity after metabolic surgery |
Q103813023 | Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus |
Q51107907 | Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. |
Q37215424 | Ectopic fat and insulin resistance |
Q50442942 | Effect of Low-Energy Diets Differing in Fiber, Red Meat, and Coffee Intake on Cardiac Autonomic Function in Obese Individuals With Type 2 Diabetes. |
Q37499849 | Effect of Sfrp5 on cytokine release and insulin action in primary human adipocytes and skeletal muscle cells. |
Q30784223 | Effect of pravastatin on responsiveness to N-monomethyl-L-arginine in patients with hypercholesterolaemia |
Q35225404 | Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study |
Q37728356 | Effectiveness of chronic care models for the management of type 2 diabetes mellitus in Europe: a systematic review and meta-analysis |
Q103800897 | Effectiveness of real-time continuous glucose monitoring to improve glycaemic control and pregnancy outcome in patients with gestational diabetes mellitus: a study protocol for a randomised controlled trial |
Q104569330 | Effects of Blood Flow Restriction Exercise and Possible Applications in Type 2 Diabetes |
Q43196308 | Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients. |
Q44155546 | Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle |
Q48381348 | Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans |
Q40649465 | Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes |
Q34629736 | Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. |
Q51245076 | Effects of supplemented isoenergetic diets varying in cereal fiber and protein content on the bile acid metabolic signature and relation to insulin resistance. |
Q91765202 | Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy |
Q90196297 | Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial |
Q90940969 | Energy metabolism of white adipose tissue and insulin resistance in humans |
Q38779718 | Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity |
Q50249509 | Erratum to: Low-energy diets differing in fibre, red meat and coffee intake equally improve insulin sensitivity in type 2 diabetes: a randomised feasibility trial. |
Q53729401 | Erratum. Association Between Long-term Exposure to Air Pollution and Biomarkers Related to Insulin Resistance, Subclinical Inflammation, and Adipokines. Diabetes 2016;65:3314-3326. |
Q56879645 | Erratum: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk |
Q48185853 | Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls |
Q87421299 | Estimates of insulin sensitivity from the intravenous-glucose-modified-clamp test depend on suppression of lipolysis in type 2 diabetes: a randomised controlled trial |
Q89671566 | Evaluation of the Metabotype Concept Identified in an Irish Population in the German KORA Cohort Study |
Q35220552 | Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans |
Q90016330 | Exosomal proteins constitute an essential part of the human adipose tissue secretome |
Q95730262 | Expansion and Impaired Mitochondrial Efficiency of Deep Subcutaneous Adipose Tissue in Recent-Onset Type 2 Diabetes |
Q35809188 | Extensive alterations of the whole-blood transcriptome are associated with body mass index: results of an mRNA profiling study involving two large population-based cohorts |
Q44018208 | FFA-induced endothelial dysfunction can be corrected by vitamin C. |
Q64975307 | FGF21 regulates insulin sensitivity following long-term chronic stress. |
Q44631034 | Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German Center for Diabetes Research |
Q46504762 | Fatty acids induce apoptosis in human smooth muscle cells depending on chain length, saturation, and duration of exposure |
Q34185998 | Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes |
Q44912956 | Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I. |
Q51246746 | Flavonoid intake from fruit and vegetables during adolescence is prospectively associated with a favourable risk factor profile for type 2 diabetes in early adulthood. |
Q34000060 | Foodborne transmission of bovine spongiform encephalopathy to non-human primates results in preclinical rapid-onset obesity |
Q83877041 | Free fatty acids normalize a rosiglitazone-induced visfatin release |
Q44641981 | Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells |
Q44896352 | Future targets in the treatment of type 2 diabetes |
Q60056848 | General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort |
Q34545454 | Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits |
Q34501150 | Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci |
Q28302158 | Genetics of type 2 diabetes: pathophysiologic and clinical relevance |
Q29417007 | Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility |
Q91608553 | German Diabetes Study - Baseline data of retinal layer thickness measured by SD-OCT in early diabetes mellitus |
Q73425047 | Ghrelin concentrations in morbidly obese patients after adjustable gastric banding |
Q37106447 | Glucose metabolism after renal transplantation |
Q39721911 | Glucose uptake saturation explains glucose kinetics profiles measured by different tests |
Q55025315 | Habitual Flavonoid Intake from Fruit and Vegetables during Adolescence and Serum Lipid Levels in Early Adulthood: A Prospective Analysis. |
Q55515105 | Habitual Fructose Intake Relates to Insulin Sensitivity and Fatty Liver Index in Recent-Onset Type 2 Diabetes Patients and Individuals without Diabetes. |
Q36942244 | Habitually higher dietary glycemic index during puberty is prospectively related to increased risk markers of type 2 diabetes in younger adulthood |
Q35766942 | Heat shock protein 60 as a mediator of adipose tissue inflammation and insulin resistance. |
Q97643920 | Hepatic Rab24 controls blood glucose homeostasis via improving mitochondrial plasticity |
Q38114744 | Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease |
Q43833544 | Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia. |
Q42475987 | Hepatic leptin signaling in obesity. |
Q91540525 | Higher GABA concentration in the medial prefrontal cortex of Type 2 diabetes patients is associated with episodic memory dysfunction |
Q91199596 | Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes |
Q125622115 | How amenable is type 2 diabetes treatment for precision diabetology? A meta-regression of glycaemic control data from 174 randomised trials |
Q86181224 | How estrogens prevent from lipid-induced insulin resistance |
Q48319325 | Hypothalamic and Striatal Insulin Action Suppresses Endogenous Glucose Production and May Stimulate Glucose Uptake During Hyperinsulinemia in Lean but Not in Overweight Men. |
Q89232690 | Identification of Comprehensive Metabotypes Associated with Cardiometabolic Diseases in the Population-Based KORA Study |
Q35945000 | Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance |
Q36560652 | Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach |
Q94588875 | Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation |
Q33932928 | Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study |
Q40045602 | Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. |
Q36466430 | Impact of common regulatory single-nucleotide variants on gene expression profiles in whole blood |
Q40362406 | Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes. |
Q92325999 | Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion |
Q37139489 | Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes. |
Q89837606 | Impairment in Baroreflex Sensitivity in Recent-Onset Type 2 Diabetes Without Progression Over 5 Years |
Q28731029 | Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial) |
Q100472663 | In vivo absolute quantification of hepatic γ-ATP concentration in mice using 31 P MRS at 11.7 T |
Q60056846 | Incidence Rates of Type 2 Diabetes in People With Impaired Fasting Glucose (ADA vs. WHO Criteria) and Impaired Glucose Tolerance: Results From an Older Population (KORA S4/F4/FF4 Study) |
Q91600774 | Increased Release of Proinflammatory Proteins in Primary Human Adipocytes and Activation of the Inflammatory NFĸB, p38, and ERK Pathways upon Omentin Treatment |
Q43660564 | Increased intake of carbohydrates from sources with a higher glycemic index and lower consumption of whole grains during puberty are prospectively associated with higher IL-6 concentrations in younger adulthood among healthy individuals |
Q44286342 | Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes |
Q46870183 | Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle |
Q73907009 | Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man |
Q44848861 | Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey |
Q40134303 | Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study |
Q51344049 | Indirect calorimetry in humans: a postcalorimetric evaluation procedure for correction of metabolic monitor variability. |
Q33834153 | Inflammatory adipokines, high molecular weight adiponectin, and insulin resistance: a population-based survey in prepubertal schoolchildren |
Q39535019 | Inflammatory markers are associated with cardiac autonomic dysfunction in recent-onset type 2 diabetes |
Q44997646 | Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial |
Q44150730 | Inhibition of glucose production and stimulation of bile flow by R (+)-alpha-lipoic acid enantiomer in rat liver |
Q86892353 | Initial clinical application of modified Dixon with flexible echo times: hepatic and pancreatic fat assessments in comparison with (1)H MRS |
Q91783622 | Insulin Resistance and Vulnerability to Cardiac Ischemia |
Q46881795 | Insulin glargine in combination with oral antidiabetic drugs as a cost-equivalent alternative to conventional insulin therapy in type 2 diabetes mellitus |
Q34507235 | Insulin infusion during normoglycemia modulates insulin secretion according to whole-body insulin sensitivity |
Q38603983 | Insulin resistance in type 1 diabetes mellitus |
Q44493426 | Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients |
Q62774275 | Insulintherapie bei Diabetes mellitus |
Q62774815 | Insulintherapie bei Diabetes mellitus |
Q101470256 | Interaction between magnesium and methylglyoxal in diabetic polyneuropathy and neuronal models |
Q52730139 | Interleukin-7 receptor α-chain haplotypes differentially affect soluble IL-7 receptor and IL-7 serum concentrations in children with type 1 diabetes. |
Q88691584 | Interorgan Metabolic Crosstalk in Human Insulin Resistance |
Q40066352 | Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study |
Q39515632 | Investigating the spill-over hypothesis: analysis of the association between local inflammatory markers in sputum and systemic inflammatory mediators in plasma |
Q39265220 | Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes |
Q28272915 | Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes |
Q56967650 | Ldlr and ApoE mice better mimic the human metabolite signature of increased carotid intima media thickness compared to other animal models of cardiovascular disease |
Q87442334 | Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS) |
Q46261519 | Lipid profiles and therapy status in the secondary prevention of high risk patients with cardiovascular disease and/or diabetes mellitus: the Austrian Hospital Screening Project (HSP) |
Q41535238 | Lipid-induced insulin resistance is not mediated by impaired transcapillary transport of insulin and glucose in humans |
Q38537208 | Lipid-mediated muscle insulin resistance: different fat, different pathways? |
Q47611058 | Lipoprotein-associated phospholipase A2 activity in obese adolescents with and without type 2 diabetes |
Q34507251 | Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. |
Q51741807 | Longitudinal associations between biomarkers of inflammation and changes in depressive symptoms in patients with type 1 and type 2 diabetes. |
Q91892959 | Longitudinal relationship of amino acids and indole metabolites with long-term body mass index and cardiometabolic risk markers in young individuals |
Q57052354 | Low Levels of Serum 25-Hydroxyvitamin D Are Associated with Increased Risk of Myocardial Infarction, Especially in Women: Results from the MONICA/KORA Augsburg Case-Cohort Study |
Q41048772 | Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry |
Q50456729 | Low-energy diets differing in fibre, red meat and coffee intake equally improve insulin sensitivity in type 2 diabetes: a randomised feasibility trial. |
Q46825787 | Lower fasting muscle mitochondrial activity relates to hepatic steatosis in humans |
Q47134766 | Lower serum extracellular superoxide dismutase levels are associated with polyneuropathy in recent-onset diabetes |
Q40682012 | MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: the KORA F4 study |
Q43157318 | Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study |
Q35150783 | Mapping the genetic architecture of gene regulation in whole blood |
Q43901570 | Mechanism of amino acid-induced skeletal muscle insulin resistance in humans |
Q46368143 | Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver |
Q37014913 | Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans |
Q59091790 | Mechanosensing by β1 integrin induces angiocrine signals for liver growth and survival |
Q50002619 | Metabolic Characteristics of Recently Diagnosed Adult-Onset Autoimmune Diabetes Mellitus. |
Q91128559 | Metabolic Determinants of Impaired Pulmonary Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus |
Q40668284 | Metabolic flexibility and oxidative capacity independently associate with insulin sensitivity in individuals with newly diagnosed type 2 diabetes |
Q96618034 | Metabolic liver disease in diabetes - from mechanisms to clinical trials |
Q112715340 | Metabolic responsiveness to training depends on insulin sensitivity and protein content of exosomes in insulin-resistant males |
Q47944286 | Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study. |
Q39398359 | Metformin Effect on Nontargeted Metabolite Profiles in Patients With Type 2 Diabetes and in Multiple Murine Tissues |
Q37783507 | Mitochondrial Function and Insulin Resistance during Aging – A Mini-Review |
Q36953482 | Mitochondrial plasticity in obesity and diabetes mellitus |
Q56962748 | Modulation of Amino Acid Metabolic Signatures by Supplemented Isoenergetic Diets Differing in Protein and Cereal Fiber Content |
Q95338040 | Monounsaturated fat rapidly induces hepatic gluconeogenesis and whole-body insulin resistance |
Q35200829 | Multi-omic signature of body weight change: results from a population-based cohort study |
Q33283340 | Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes |
Q37035872 | Muscular mitochondrial dysfunction and type 2 diabetes mellitus |
Q88170532 | Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study |
Q35778812 | Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes |
Q28270700 | New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk |
Q102318139 | Non-alcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans |
Q39986083 | Non-conventional markers of atherosclerosis before and after gastric banding surgery |
Q83753630 | Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy |
Q92762247 | Novel Insights into Sensorimotor and Cardiovascular Autonomic Neuropathy from Recent-Onset Diabetes and Population-Based Cohorts |
Q36321634 | Novel biomarkers for pre-diabetes identified by metabolomics |
Q34221038 | Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals |
Q91351180 | Omentin-regulated proteins combine a pro-inflammatory phenotype with an anti-inflammatory counterregulation in human adipocytes: A proteomics analysis |
Q46670120 | Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. |
Q87228705 | Overexpression of cutaneous mitochondrial superoxide dismutase in recent-onset type 2 diabetes |
Q88018510 | Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients |
Q33617402 | PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort |
Q30903914 | Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans |
Q86238090 | Pancreatic triacylglycerol distribution in type 2 diabetes. Reply to Hollingsworth K. G., Al Mrabeh A., Steven S. et al [letter] |
Q47797122 | Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy |
Q36265019 | Perceived risk of diabetes seriously underestimates actual diabetes risk: The KORA FF4 study |
Q86047296 | Perilipin 5: from fatty liver to hepatic lipodystrophy? |
Q48534624 | Perturbation of the molecular clockwork in the SCN of non-obese diabetic mice prior to diabetes onset. |
Q24648472 | Phosphoenolpyruvate cycling via mitochondrial phosphoenolpyruvate carboxykinase links anaplerosis and mitochondrial GTP with insulin secretion |
Q40055201 | Plasma Concentrations of Afamin Are Associated With Prevalent and Incident Type 2 Diabetes: A Pooled Analysis in More Than 20,000 Individuals |
Q44954012 | Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus |
Q44968774 | Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding |
Q35043435 | Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes. |
Q51246450 | Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index. |
Q99247480 | Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experiment |
Q40345626 | Proinflammatory Cytokines Predict the Incidence and Progression of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study |
Q45923810 | Pronounced reduction of cutaneous Langerhans cell density in recently diagnosed type 2 diabetes. |
Q90835896 | Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study |
Q43612708 | Public health aspects of diabetes mellitus--epidemiology, prevention strategies, policy implications: the first Austrian diabetes report. |
Q34325851 | Quantifying the improvement of surrogate indices of hepatic insulin resistance using complex measurement techniques |
Q86999725 | Quantitative liver 31P magnetic resonance spectroscopy at 3T on a clinical scanner |
Q34097785 | RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studies |
Q44511984 | Rare cause for severe hypertriglyceridemia - case 9/2013 |
Q93550990 | Re-establishment of normal blood flow is mandatory to restore intramuscular high energy phosphate levels after transient ischemia |
Q104684271 | Reduced Muscle Strength Associates with Insulin Resistance in Type 2 Diabetes Patients with Osteoarthritis |
Q33394238 | Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly |
Q58760432 | Reduced expression of stearoyl-CoA desaturase-1, but not free fatty acid receptor 2 or 4 in subcutaneous adipose tissue of patients with newly diagnosed type 2 diabetes mellitus |
Q44168141 | Reduction of hepatic glycogen synthesis and breakdown in patients with agenesis of the dorsal pancreas |
Q42450511 | Reduction of non-esterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: a randomised clinical trial |
Q44215074 | Reduction of plasma leptin concentrations by arginine but not lipid infusion in humans |
Q59795306 | Regional differences of macrovascular disease in Northeast and South Germany: the population-based SHIP-TREND and KORA-F4 studies |
Q34527018 | Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors |
Q51469490 | Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery. |
Q45086415 | Relationship between serum lipoprotein ratios and insulin resistance in obesity |
Q47365110 | Relationship of Serum Fetuin A with Metabolic and Clinical Parameters in German Children and Adolescents with Type 1 Diabetes |
Q43967497 | Renal hemodynamic effects of somatostatin are not related to inhibition of endogenous insulin release |
Q48336886 | Reply to: mitochondrial diabetes in Germany and Austria. |
Q92183739 | Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study |
Q99345918 | Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes |
Q102220005 | Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans |
Q33854029 | Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans |
Q80249128 | Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction |
Q47138654 | Sequence data and association statistics from 12,940 type 2 diabetes cases and controls |
Q35560934 | Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD) |
Q37615936 | Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study |
Q90038187 | Serum uromodulin is inversely associated with the metabolic syndrome in the KORA F4 study |
Q51286748 | Sfrp5 associates with beta-cell function in humans. |
Q51260857 | Sfrp5 correlates with insulin resistance and oxidative stress. |
Q64108754 | Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E |
Q91018225 | Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial |
Q37193670 | Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes |
Q28207796 | Short-term leptin-dependent inhibition of hepatic gluconeogenesis is mediated by insulin receptor substrate-2 |
Q33968101 | Skeletal muscle phosphodiester content relates to body mass and glycemic control |
Q34105888 | Socioeconomic factors and effect of evidence-based patient information about primary prevention of type 2 diabetes mellitus--are there interactions? |
Q36309112 | Spatial analysis improves the detection of early corneal nerve fiber loss in patients with recently diagnosed type 2 diabetes |
Q54981488 | Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis. |
Q40939363 | Specific Metabolic Profiles and Their Relationship to Insulin Resistance in Recent-Onset Type 1 and Type 2 Diabetes. |
Q29417103 | Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases |
Q28659854 | Systematic identification of trans eQTLs as putative drivers of known disease associations |
Q33824231 | Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. |
Q57414509 | TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary events |
Q33737477 | The Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ Genotype |
Q42686318 | The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. |
Q35666911 | The Human Blood Metabolome-Transcriptome Interface |
Q33599932 | The Janus Head of Oxidative Stress in Metabolic Diseases and During Physical Exercise |
Q79848490 | The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man |
Q40759836 | The Role of Markers of Low-Grade Inflammation for the Early Time Course of Glycemic Control, Glucose Disappearance Rate, and β-Cell Function in Recently Diagnosed Type 1 and Type 2 Diabetes |
Q47685121 | The effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial |
Q29583824 | The genetic architecture of type 2 diabetes |
Q91698411 | The integrative biology of type 2 diabetes |
Q46585064 | The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes |
Q35711963 | The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans |
Q37913662 | The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact |
Q37930956 | The role of mitochondria in insulin resistance and type 2 diabetes mellitus |
Q38492567 | The role of mitochondria in statin-induced myopathy |
Q36265959 | The transcriptional landscape of age in human peripheral blood |
Q45301735 | Therapy with oral antidiabetic drugs |
Q43829611 | Thiazolidinediones influence plasma steroids of male obese Zucker rats |
Q44816749 | Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? |
Q87534398 | Thymic epithelium determines a spontaneous chronic neuritis in Icam1(tm1Jcgr)NOD mice |
Q41283257 | Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients |
Q49064604 | Tissue-specific differences in the development of insulin resistance in a mouse model for type 1 diabetes. |
Q38636258 | Transcriptome-Wide Analysis Identifies Novel Associations With Blood Pressure |
Q37364952 | Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002. |
Q24609915 | Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis |
Q36904049 | Type 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction |
Q45056713 | Validity and reproducibility of an interviewer-administered food frequency questionnaire in Austrian adults at risk of or with overt diabetes mellitus |
Q40743606 | Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes |
Q39827340 | Vascular function in obese children with non-alcoholic fatty liver disease |
Q57414516 | Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study |
Q90701561 | Vitamin B12 and folate concentrations in recent-onset type 2 diabetes and the effect of metformin treatment |
Q64218085 | Vom Labor zum Patienten – Translationale Diabetesforschung |
Q58582478 | What information needs do people with recently diagnosed diabetes mellitus have and what are the associated factors? A cross-sectional study in Germany |
Q54185230 | [A rare cause of diabetes mellitus]. |
Q93066698 | [Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)] |
Q93066716 | [Diabetes mellitus-Definition, classification, diagnosis, screening and prevention (Update 2019)] |
Q93066680 | [Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2019)] |
Q93066694 | [Insulin therapy of type 2 diabetes mellitus (Update 2019)] |
Q53867997 | [The adipose tissue as an endocrine organ]. |
Q62775584 | [Therapy with insulin] |
Michael Roden | wikipedia | |
Michael Roden | wikipedia |
Search more.